Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Treatment of nucleic acid

a nucleic acid and nucleic acid technology, applied in the field of nucleic acid treatment, can solve the problems of loss of up to about 96% of the nucleic acid sample, and about 4% of the nucleic acid is actually available for analysis, and achieve the effect of minimizing the loss of the sampl

Inactive Publication Date: 2007-01-25
HUMAN GENETIC SIGNATURES PTY LTD
View PDF17 Cites 33 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The invention is a method for treating nucleic acids with a bisulphite reagent to modify methylated nucleotides with sulphonate groups. The method is efficient, adaptable for many different molecular biological techniques, and can achieve significant retention of nucleic acid. The method includes denaturing the nucleic acid sample, incubating it with the bisulphite reagent, diluting it, precipitating it, and reacting it to remove sulphonate groups. The method can be carried out without causing any substantial degradation or loss of the nucleic acid sample. The method can further be processed or analyzed. The kits containing reagents and instructions to carry out the method are also provided."

Problems solved by technology

In contrast, bisulphite methods presently in use or described in the prior art typically result in loss of up to about 96% of the nucleic acid sample so that only about 4% of the nucleic acid is actually available for analysis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment of nucleic acid
  • Treatment of nucleic acid
  • Treatment of nucleic acid

Examples

Experimental program
Comparison scheme
Effect test

examples

Methods and Reagents

[0082] Chemicals were obtained as follows: Agarose from BioRad (Hercules Calif.; certified molecular biology grade #161-3101); Acetic acid, glacial, from BDH (Kylsyth, Australia; AnalaR 100015N); ethylenediamine tetraacetic acid (EDTA) from BDH (AnalaR 10093.5V); Ethanol from Aldrich (St. Louis Mo.; 200 proof E702-3); Isopropanol from Sigma (St. Louis Mo.; 99%+Sigma I-9516); Mineral oil from Sigma (M-5904); Sodium acetate solution 3M from Sigma (S-7899); Sodium chloride from Sigma (ACS reagent S9888); and Sodium hydroxide from BDH (AnalaR #10252.4X).

[0083] Enzymes / Reagents were obtained as follows: EcoR1 from Roche (Indianapolis Ind.; #87930626, 10 units / μl); HindIII from Biolabs (Beverly Mass.; #R01045, 10 units / μl); PCR master mix from Promega (Madison Wis; #M7505); and DNA markers from Sigma (Direct load PCR low ladder 100-1000 bp, Sigma D-3687 and 100-10 Kb, Sigma D-7058).

[0084] Solutions were as follows: (1) 10 mM Tris / 0.1M EDTA, pH 7.0-12.5; (2) 3M NaOH...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The invention provides methods for treating nucleic acid, particularly nucleic acid that is methylated. In one embodiment, the method can include the steps of (a) providing a denaturing environment to a nucleic acid sample; (b) reacting the nucleic acid sample with a bisulphite reagent and incubating the reaction so as to form a treated nucleic acid sample where methylated nucleotides in the nucleic acid sample remain unchanged while unmethylated nucleotides are converted to another form; (c) diluting the treated nucleic acid sample so as to reduce salt concentration to a level which will not substantially interfere with a nucleic acid precipitating step; (d) precipitating the diluted treated nucleic acid to substantially remove any unwanted reagents or diluents from treated nucleic acid; and (e) carrying out de-sulphonation of the precipitated treated nucleic acid so as to remove sulphonate groups present on the treated nucleic acid so as to obtain a nucleic acid sample substantially free of sulphonate groups.

Description

TECHNICAL FIELD [0001] The present invention relates to modified methods for treating nucleic acid, particularly methylated nucleic acid using bisulphite. BACKGROUND [0002] As a result of advances in automated sequencing technology, much work has been carried out on determining coding regions of DNA resulting in the full sequencing of many animal genomes including the human genome. It has been realised for many years that the majority of genomic DNA, however, is non-coding and this material was once considered as “junk” DNA. Analysis of the non-coding regions of DNA is now being considered as important in the study of gene expression and function. Methylation states or patterns in nucleic acid, particularly genomic DNA, is thought to have a functional or regulatory role in gene expression and control in animals. [0003] It has been demonstrated that, in single stranded DNA, sodium bisulphite preferentially deaminates cytosine to uracil, compared to a very slow rate of deamination of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68C07H21/04
CPCC07H21/04C12Q1/68C12Q1/6827C12Q2523/125C12Q2527/119
Inventor MILLAR, DOUGLAS SPENCERVOCKLER, CASSANDRA JEAN
Owner HUMAN GENETIC SIGNATURES PTY LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products